WASHINGTON, D.C. – In a wide-ranging interview for The Virtual MedTech Conference this week, FDA Commissioner Dr. Stephen Hahn spoke with AdvaMed President and CEO Scott Whitaker on the importance of Americans’ continued confidence in the integrity of the agency’s science-based product review process.
WASHINGTON, D.C.– The Virtual MedTech Conference, powered by AdvaMed, kicks off three days of livestream events tomorrow with morning to afternoon sessions featuring an international perspective on the COVID-19 pandemic, a look at the next generation of U.S. voters, a fireside chat with FDA Commissioner Hahn, a discussion on diversity and health care disparities, and insights from key CMS officials.
WASHINGTON, D.C. – AdvaMed released the following statements on the announcement last night that Quidel Corporation, a member company of AdvaMed and AdvaMedDx, received Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration of “a rapid point-of-care test to be used with the Sofia® 2 Fluorescent Immunoassay Analyzer for the rapid, simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) and nasal (NS) swab specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider within the first five days of the onset of symptoms.”
WASHINGTON, D.C. – To help realize the potential of digital health technologies to improve patient care, today the Advanced Medical Technology Association (AdvaMed) issued a white paper detailing recommendations to modernize Medicare coverage and payment policies so that beneficiaries can have greater access to the latest digital health innovations.
WASHINGTON, DC. – The Advanced Medical Technology Association (AdvaMed) today announced that former Guidant CEO Ronald “Ron” W. Dollens will receive the 2020 AdvaMed Lifetime Achievement Award at the industry’s premier annual gathering – The Virtual MedTech Conference – during a livestream session Oct. 6 at 2:30 pm ET.
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical devices in the world, and AdvaMed Accel, the leading advocacy association for emerging medtech firms, today announced that Vena Vitals has been awarded the 2020 MedTech Innovator Execution Award and the Virginia Shimer Rybski Memorial Award.
WASHINGTON, D.C.– The life-changing impact of medical technologies on individuals’ lives is the story during Week 4 of The Virtual MedTech Conference, powered by AdvaMed, with the opening of this year’s Patient Pavilion.
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data shows that innovative diagnostics companies are shipping, on average, 1.2 million molecular tests each day.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced the launch of a website dedicated to protecting patients from misleading litigation advertising. The Responsible Advertising for Patient Safety website aims to drive and enhance awareness of the dangers of misleading ads for medtech litigation, including a behind-the-scenes look at litigation funding practices of plaintiff attorneys.
WASHINGTON, D.C. – As part of the medtech industry’s ongoing mobilization to combat COVID-19, the Advanced Medical Technology Association (AdvaMed) today announced that through the Standards Alliance mechanism, a multi-year partnership has been approved under which the association will provide private sector resources and expertise to help increase adoption of medical technology-specific international regulatory standards and good regulatory practices by governments across Latin America, Africa, and Southeast Asia.